Effect of Semaglutide 2.4 mg on Use of Antihypertensive and Lipid-lowering Treatment in STEP Trials

被引:0
|
作者
Knight, Michael
Adelborg, Kasper
Clements, Jennifer
Iversen, Aske Thorn
Laursen, Peter
Tchang, Beverly
Traina, Andrea
机构
关键词
D O I
暂无
中图分类号
R5 [内科学];
学科分类号
1002 ; 100201 ;
摘要
Poster-494
引用
收藏
页码:250 / 250
页数:1
相关论文
共 50 条
  • [21] Use of antihypertensive and lipid-lowering drugs: the management of cardiovascular risk in clinical practice
    Di Martino, M.
    Degli Esposti, L.
    Filigheddu, F.
    Veronesi, C.
    Salerno, G.
    Saragoni, S.
    Glorioso, N.
    Didoni, G.
    Degli Esposti, E.
    JOURNAL OF HUMAN HYPERTENSION, 2007, 21 (01) : 53 - 59
  • [22] Use of antihypertensive and lipid-lowering drugs: the management of cardiovascular risk in clinical practice
    M Di Martino
    L Degli Esposti
    F Filigheddu
    C Veronesi
    G Salerno
    S Saragoni
    N Glorioso
    G Didoni
    E Degli Esposti
    Journal of Human Hypertension, 2007, 21 : 53 - 59
  • [23] The Use of Antidiabetic, Antihypertensive, and Lipid-lowering Medications in the Elderly Dying with Advanced Cancer
    Al-Shahri, Mohammad Zafir
    Sroor, Mahmoud Yassein
    Ghareeb, Wael Ali
    Aboulela, Enas Noshy
    Edesa, Wael
    INDIAN JOURNAL OF PALLIATIVE CARE, 2019, 25 (01) : 124 - 126
  • [24] Stroke results in the antihypertensive and lipid-lowering treatment to prevent heart attack trial
    Oparil, S
    Davis, BR
    Nwachuku, C
    Pressel, S
    deLeon, B
    STROKE, 2004, 35 (01) : 235 - 235
  • [25] Angioedema in the antihypertensive and lipid-lowering treatment to prevent heart attack trial (ALLHAT)
    Piller, L
    Ford, C
    Davis, B
    Nwachuku, C
    Black, H
    Oparil, S
    Gappy, S
    Retta, T
    Probstfield, J
    AMERICAN JOURNAL OF HYPERTENSION, 2005, 18 (05) : 92A - 92A
  • [26] COMBINED ANTIHYPERTENSIVE AND LIPID-LOWERING THERAPY IN EXPERIMENTAL GLOMERULONEPHRITIS
    RUBIN, R
    SILBIGER, S
    SABLAY, L
    NEUGARTEN, J
    HYPERTENSION, 1994, 23 (01) : 92 - 95
  • [27] Predictors of adherence with concomitant antihypertensive and lipid-lowering therapy
    Chapman, RH
    Benner, JS
    Petrilla, AA
    Tierce, JC
    Battleman, DS
    Schwartz, JS
    VALUE IN HEALTH, 2004, 7 (03) : 319 - 319
  • [28] Inflammation and lipid-lowering treatment
    Ballantyne C.M.
    Abe Y.
    Current Cardiology Reports, 1999, 1 (3) : 251 - 255
  • [29] SAFETY OF LIPID-LOWERING TREATMENT
    Elikir, G.
    Hesse, E.
    Sanchez, R.
    Baglivo, H.
    ATHEROSCLEROSIS SUPPLEMENTS, 2008, 9 (01) : 195 - 196
  • [30] Effect of the Antihypertensive and Lipid-Lowering Treatment to Prevent Heart Attack Trial (ALLHAT) on Conduction System Disease
    Dewland, Thomas A.
    Soliman, Elsayed Z.
    Davis, Barry R.
    Magnani, Jared W.
    Yamal, Jose-Miguel
    Piller, Linda B.
    Haywood, L. Julian
    Alonso, Alvaro
    Albert, Christine M.
    Marcus, Gregory M.
    JAMA INTERNAL MEDICINE, 2016, 176 (08) : 1085 - 1092